Gefitinib is effective against colorectal tumor cells that express high levels of EGFR, and there is ongoing clinical evaluation of the efficacy of gefitinib in combination with CPT-11, in the treatment of colorectal cancers [34]. This evidence concerns the gene EGFR and colorectal cancer.